Literature DB >> 8608636

Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD).

G Bouma1, B Xia, J B Crusius, G Bioque, I Koutroubakis, B M Von Blomberg, S G Meuwissen, A S Peña.   

Abstract

In 153 patients with IBD, 64 with Crohn's disease (CD), and 89 with ulcerative colitis (UC), as well as in 54 healthy controls (HC), the frequencies of four known di-allelic polymorphisms in the genes for TNF-alpha and lymphotoxin alpha (LTalpha) were investigated. In the Dutch population, the alleles of these four polymorphisms are present in only five combinations, called TNF haplotypes: TNF-C, -E, -H, -I, -P. Furthermore, the relation with the presence of perinuclear anti-neutrophil cytoplasmic autoantibodies (P-ANCA) was studied. A small, but statistically significant, association between the polymorphism at position -308 in the promoter region of the TNF-alpha gene and UC was found. The frequency of the uncommon TNF-alpha -308 allele 2 was found to be decreased in patients with UC compared with HC (allele frequency of allele 2 in UC patients 0-15 versus 0.25 in HC, P=0.044). No significant differences in distribution of the TNF haplotypes were found between IBD patients and HC, although there was a tendency towards a higher frequency of the TNF-C haplotype in UC patients compared with controls (haplotype frequency 22% versus 13%; P=0.19). No statistically significant differences in distribution of the TNF haplotypes were observed between P-ANCA-positive and P-ANCA-negative UC patients. The strength of the associations indicates that TNF genes are not markers for the predisposition to suffer from IBD. They may, however, be markers of subsets of patients with UC and CD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608636      PMCID: PMC2200378          DOI: 10.1111/j.1365-2249.1996.tb08292.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product.

Authors:  A G Wilson; F S di Giovine; A I Blakemore; G W Duff
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

2.  A new restriction fragment length polymorphism of the human TNF-B gene detected by AspHI digest.

Authors:  S Ferencik; M Lindemann; B Horsthemke; H Grosse-Wilde
Journal:  Eur J Immunogenet       Date:  1992-12

3.  Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity.

Authors:  F Shanahan; R H Duerr; J I Rotter; H Yang; L R Sutherland; C McElree; C J Landers; S R Targan
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

4.  Genetics of inflammatory bowel disease.

Authors:  J Satsangi; D P Jewell; W M Rosenberg; J I Bell
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

5.  Distinct associations of HLA class II genes with inflammatory bowel disease.

Authors:  H Toyoda; S J Wang; H Y Yang; A Redford; D Magalong; D Tyan; C K McElree; S R Pressman; F Shanahan; S R Targan
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

6.  Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.

Authors:  H Yang; J I Rotter; H Toyoda; C Landers; D Tyran; C K McElree; S R Targan
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  A polymorphic variation in a putative regulation box of the TNFA promoter region.

Authors:  S D'Alfonso; P M Richiardi
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis.

Authors:  K Sugimura; H Asakura; N Mizuki; M Inoue; T Hibi; A Yagita; K Tsuji; H Inoko
Journal:  Hum Immunol       Date:  1993-02       Impact factor: 2.850

9.  Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.

Authors:  M Oudkerk Pool; P M Ellerbroek; B U Ridwan; R Goldschmeding; B M von Blomberg; A S Peña; K M Dolman; H Bril; W Dekker; J J Nauta
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

10.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.

Authors:  A G Wilson; N de Vries; F Pociot; F S di Giovine; L B van der Putte; G W Duff
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  36 in total

Review 1.  Genetic aspects of inflammatory bowel disease: how far have we come, and where are we heading?

Authors:  J Cho
Journal:  Curr Gastroenterol Rep       Date:  1999-12

2.  A meta-analysis on the association between three promoter variants of TNF-α and Crohn's disease.

Authors:  Cui Xie; Xiao Feng Liu; Mao Sheng Yang
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

3.  Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort.

Authors:  N Senhaji; A Serrano; W Badre; N Serbati; M Karkouri; Y Zaid; S Nadifi; J Martin
Journal:  Genes Immun       Date:  2015-12-03       Impact factor: 2.676

Review 4.  Genetic factors associated with the development of inflammatory bowel disease.

Authors:  Jesus-K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

5.  Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk.

Authors:  Lynnette R Ferguson; Claudia Huebner; Ivonne Petermann; Richard B Gearry; Murray L Barclay; Pieter Demmers; Alan McCulloch; Dug Yeo Han
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

6.  In vitro production of TNF-alpha,IL-6 and sIL-2R in Chinese patients with ulcerative colitis.

Authors:  Bing Xia; Hai-Jian Guo; JBA Crusius; Chang-Sheng Deng; SGM Meuwissen; AS Pena
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

7.  Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid.

Authors:  D J Conway; M J Holland; R L Bailey; A E Campbell; O S Mahdi; R Jennings; E Mbena; D C Mabey
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

8.  Genetic markers in clinically well defined patients with ulcerative colitis (UC).

Authors:  G Bouma; J B Crusius; M A García-González; B U Meijer; H P Hellemans; R J Hakvoort; G M Schreuder; P J Kostense; S G Meuwissen; A S Peña
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

9.  TNFalpha*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans.

Authors:  J Wattavidanage; R Carter; K L Perera; A Munasingha; S Bandara; D McGuinness; A R Wickramasinghe; H K Alles; K N Mendis; S Premawansa
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

10.  Infliximab in ulcerative colitis.

Authors:  Avi Levin; Oren Shibolet
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.